benzoxazoles has been researched along with cabozantinib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calvisi, DF; Che, L; Chen, X; Cigliano, A; Evert, M; Liang, B; Lu, X; Shang, R; Song, X; Utpatel, K; Wang, J; Wang, P; Xu, M; Zhou, Y | 1 |
| Calvisi, DF; Chen, K; Chen, X; Evert, M; Li, B; Shang, R; Song, X; Xu, H; Zhang, Y; Zhong, S | 1 |
2 other study(ies) available for benzoxazoles and cabozantinib
| Article | Year |
|---|---|
Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma.
Topics: Anilides; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzoxazoles; Carcinoma, Hepatocellular; Cell Line, Tumor; Female; Humans; Immune Checkpoint Inhibitors; Liver Neoplasms; Liver Neoplasms, Experimental; Pyridines; Pyrimidines; Tumor Microenvironment | 2021 |
Alpelisib combination treatment as novel targeted therapy against hepatocellular carcinoma.
Topics: Anilides; Animals; Benzoxazoles; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Disease Models, Animal; Female; Humans; Liver Neoplasms; MAP Kinase Signaling System; Mice; Molecular Targeted Therapy; Mutation; Piperazines; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; PTEN Phosphohydrolase; Pyridines; Pyrimidines; Thiazoles; Treatment Outcome; Tumor Burden | 2021 |